Berkan Kurt: Inflammatory Biomarkers in Heart Failure
Berkan Kurt, Resident Physician in Cardiology and Internal Medicine at Uniklinik RWTH Aachen, reposted from Florian Kahles, on LinkedIn:
“In our new review, we look at heart failure with a focus on chronic low-grade inflammation, discuss how hsCRP, IL-6 and other biomarkers capture residual inflammatory risk in HFpEF and HFrEF and may help guide future anti-inflammatory strategies.
Also excited to share that this is the first publication of our MD student Konstantin Rex, who co-led the work. ”
Quoting Florian Kahles’s post:
“Happy to share our new review in Current Heart Failure Reports, “Inflammatory Biomarkers in Heart Failure: Clinical Perspectives on hsCRP, IL-6 and Emerging Candidates.”
We summarize how low-grade systemic inflammation drives HF pathobiology and outline the complementary roles of hsCRP as a practical risk marker and IL-6 as a causal pathway with therapeutic potential.
We also discuss implications for risk stratification, precision medicine, and ongoing IL-6–targeted trials in HF.”
Read the full article here.
Article: Inflammatory Biomarkers in Heart Failure: Clinical Perspectives on hsCRP, IL-6 and Emerging Candidates
Authors: Berkan Kurt, Konstantin Rex, Martin Reugels, Christopher B. Fordyce, Marat Fudim, Abhinav Sharma, Martin Berger, Nikolaus Marx, Katharina Marx-Schütt, Florian Kahles

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 30, 2026, 18:36Amina Ammar: Evaluating Rivaroxaban Dosing Alignment Across Cockcroft–Gault and eGFR Equations
-
Jul 30, 2026, 18:11Tobias Tritschler: Evaluating Timing, Translation and Preparedness in COVID-19 Anticoagulation Management
-
Jul 30, 2026, 16:05Peter Zdziarski: Today is Chronic Disease Awareness Day
-
Jul 30, 2026, 15:50Ahmad Gharehbaghian: New Blood Transfusion Centers Open in Iran
-
Jul 30, 2026, 15:32Can We Better Protect Hospitalized Patients With Obesity From Venous Thromboembolism? – RPTH Journal
-
Jul 30, 2026, 15:162025 Platelet Transfusion Thresholds: When to Transfuse and When Not to Transfuse – Chokri Ben Lamine
-
Jul 30, 2026, 14:34Flora Peyvandi: Genetics of Early-Onset Coronary Artery Disease in Iranians
-
Jul 30, 2026, 14:22Stéphanie Forté: New Evidence Strengthens the Case for Hydroxyurea in HbSC Disease
-
Jul 30, 2026, 14:09Hilal Ahmad: New Guidelines for Pediatric Ischemic Stroke Management